Home > Healthcare > Medical Devices > Therapeutic Devices > Wearable Injectors Market

Wearable Injectors Market Trends

Report ID: GMI5891
Published Date: May 2023
Report Format: PDF

Download Free Sample

Wearable Injectors Market Trends

The expanding geriatric population is a chief factor driving the demand for healthcare services and medication, which is fostering the business outlook. Wearable injectors cater to the needs of elderly patients who may have difficulties with traditional injection methods. The ability to self-administer medication at home promotes independence and improves the quality of life for older individuals. Furthermore, a growing emphasis on personalized medicine, where treatments are tailored to individual patients based on their unique characteristics and needs is complementing industry development.

Authors: Mariam Faizullabhoy , Subodh Kharad

Frequently Asked Questions (FAQ) :

Global market for wearable injectors was worth USD 8 billion in 2022 and will progress at more than 13.5% CAGR between 2023 and 2032 propelled by the growing prevalence of chronic diseases, including immunological disorders, diabetes, cardiovascular diseases, and cancer, among others.

The on-body segment is poised to reach more than USD 15 billion in revenue by 2032 as a result of continuous improvements in wearable injector design, specs, and technology that offer ergonomic design, compact device, and water resistance advantages.

The diabetes application segment will be valued at USD 9 billion by 2032 owing to the positive inclination of healthcare professionals owing to numerous advantages for managing diabetes.

North America wearable injectors market is slated to grow at more than 13.5% CAGR over 2023-2032 on account of the high prevalence of diabetes and advanced healthcare infrastructure in the region.